Literature DB >> 11268382

The role of bim, a proapoptotic BH3-only member of the Bcl-2 family in cell-death control.

A Strasser1, H Puthalakath, P Bouillet, D C Huang, L O'Connor, L A O'Reilly, L Cullen, S Cory, J M Adams.   

Abstract

Apoptosis is an evolutionarily conserved process for killing unwanted cells. Genetic and biochemical experiments have indicated that three groups of proteins are necessary for activation of the cell-death effector machinery: cysteine proteases, their adaptors, and proapoptotic Bcl-2 family members. Antiapoptotic Bcl-2 family members are needed for cell survival. We have cloned Bim, a proapoptotic Bcl-2 family member that shares with the family only a 9-16 aa region of homology [Bcl-3 homology region(BH3)], but is otherwise unique. Bim requires its BH3 region for binding to Bcl-2 and activation of apoptosis. Analysis of Bim-deficient mice has shown that Bim is essential for the execution of some but not all apoptotic stimuli that can be antagonized by Bcl-2. Bim-deficient mice have increased numbers of lymphocytes, plasma cells, and myeloid cells, and most develop fatal autoimmune glomerulonephritis. In healthy cells, Bim is bound to the microtubule-associated dynein motor complex, and is thereby sequestered from Bcl-2. Certain apoptotic signals unleash Bim and allow it to translocate to intracellular membranes, where it interacts with Bcl-2 or its homologues. These results indicate that BH3-only proteins are essential inducers of apoptosis that can be unleashed by certain death signals. Unleashed BH3-only proteins neutralize the prosurvival function of Bcl-2-like molecules, and this is thought to liberate Apaf-l-like adapters to activate caspase zymogens, which then initiate cell degradation.

Entities:  

Mesh:

Year:  2000        PMID: 11268382     DOI: 10.1111/j.1749-6632.2000.tb05419.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  39 in total

Review 1.  Cell cycle molecules define a pathway required for neuron death in development and disease.

Authors:  Lloyd A Greene; David X Liu; Carol M Troy; Subhas C Biswas
Journal:  Biochim Biophys Acta       Date:  2006-12-13

2.  Rapid degradation of Bim by the ubiquitin-proteasome pathway mediates short-term ischemic tolerance in cultured neurons.

Authors:  Robert Meller; Jennifer Anastasia Cameron; Daniel John Torrey; Corrin Erin Clayton; Andrea Nicole Ordonez; David Clifford Henshall; Manabu Minami; Clara Kay Schindler; Julie Anne Saugstad; Roger Pancoast Simon
Journal:  J Biol Chem       Date:  2006-01-23       Impact factor: 5.157

3.  Regulation of bim in glucocorticoid-mediated osteoblast apoptosis.

Authors:  B Espina; M Liang; R G G Russell; P A Hulley
Journal:  J Cell Physiol       Date:  2008-05       Impact factor: 6.384

4.  Regulation of lymphocyte progenitor survival by the proapoptotic activities of Bim and Bid.

Authors:  Malay Mandal; Kelly M Crusio; Fanyong Meng; Suqing Liu; Marcus Kinsella; Marcus R Clark; Osamu Takeuchi; Iannis Aifantis
Journal:  Proc Natl Acad Sci U S A       Date:  2008-12-16       Impact factor: 11.205

5.  Critical roles of Bim in T cell activation and T cell-mediated autoimmune inflammation in mice.

Authors:  Maciej W Ludwinski; Jing Sun; Brendan Hilliard; Shunyou Gong; Fan Xue; Ruaidhri J Carmody; Jennifer DeVirgiliis; Youhai H Chen
Journal:  J Clin Invest       Date:  2009-06       Impact factor: 14.808

6.  NF-kappaB1 and c-Rel cooperate to promote the survival of TLR4-activated B cells by neutralizing Bim via distinct mechanisms.

Authors:  Ashish Banerjee; Raelene Grumont; Raffi Gugasyan; Christine White; Andreas Strasser; Steve Gerondakis
Journal:  Blood       Date:  2008-09-19       Impact factor: 22.113

Review 7.  Calcium Signaling: From Normal B Cell Development to Tolerance Breakdown and Autoimmunity.

Authors:  Patrice Hemon; Yves Renaudineau; Marjolaine Debant; Nelig Le Goux; Sreya Mukherjee; Wesley Brooks; Olivier Mignen
Journal:  Clin Rev Allergy Immunol       Date:  2017-10       Impact factor: 8.667

8.  Short-term inhibition of p53 combined with keratinocyte growth factor improves thymic epithelial cell recovery and enhances T-cell reconstitution after murine bone marrow transplantation.

Authors:  Ryan M Kelly; Emily M Goren; Patricia A Taylor; Scott N Mueller; Heather E Stefanski; Mark J Osborn; Hamish S Scott; Elena A Komarova; Andrei V Gudkov; Georg A Holländer; Bruce R Blazar
Journal:  Blood       Date:  2009-12-04       Impact factor: 22.113

9.  Combination of novel proteasome inhibitor NPI-0052 and lenalidomide trigger in vitro and in vivo synergistic cytotoxicity in multiple myeloma.

Authors:  Dharminder Chauhan; Ajita V Singh; Bryan Ciccarelli; Paul G Richardson; Michael A Palladino; Kenneth C Anderson
Journal:  Blood       Date:  2009-11-13       Impact factor: 22.113

Review 10.  The role of the ubiquitin proteasome system in ischemia and ischemic tolerance.

Authors:  Robert Meller
Journal:  Neuroscientist       Date:  2009-01-30       Impact factor: 7.519

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.